After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
GSK belongs to the Healthcare sector of the NYSE while operating in the Drug Manufacturers – General industry. The current market capitalization of GSK Plc ADR is $74.43B. A total of 4.54 million shares were traded on the day, compared to an average of 4.93M shares.
In the most recent transaction, GSK plc bought 2,791,930 shares of GSK for 8.00 per share on Sep 27 ’24. After the transaction, the 10% Owner now owns 16,775,691 company shares.
Dividend
Paying dividends generates immediate cash flow for investors and indicates a positive outlook for the company. GSK Plc ADR pays an annual dividend of $1.56, resulting in a dividend yield of 4.27%, and it has a price to earnings (P/E) ratio of 23.05. GSK’s most recent ex-dividend date was 4.2% when it declared a $0.3932 quarterly dividend that was paid in cash on 2/21/2025. Previously, the company paid the dividend on 11/15/2024 with an ex-dividend date of 4.1%. The GSK stock dividend was $0.3928 per share in cash.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, GSK has a high of $45.92 and a low of $31.72.
As of this writing, GSK has an earnings estimate of $1.01 per share for the current quarter. EPS was calculated based on a consensus of 2.0 estimates, with a high estimate of $1.07 per share and a lower estimate of $0.96.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. GSK’s latest balance sheet shows that the firm has $4.13B in Cash & Short Term Investments as of fiscal 2021. There were $24.17B in debt and $23.67B in liabilities at the time. Its Book Value Per Share was $8.39, while its Total Shareholder’s Equity was $21.34B.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for GSK is Buy with a score of 3.23.
